Analystreport

Takeda Pharmaceutical Company Limited (NYSE: TAK) had its price target lowered by analysts at JPMorgan Chase & Co. from $14.20 to $14.00.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK)